Form 4: VolitionRx Executive Gael Forterre Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Chief Commercial Officer Gael Forterre reports a transaction involving the withholding of shares to cover tax obligations related to restricted stock units.
Summary
- On September 28, 2024, VolitionRx's Chief Commercial Officer, Gael Forterre, had 4,824 shares of common stock withheld by the company to cover tax obligations upon the settlement of 13,725 restricted stock units.
- The shares were withheld at a price of $0.578 per share.
- Following the transaction, Forterre directly owns 157,786 shares of common stock.
- Forterre also indirectly owns 5,000 shares through his spouse and 32,500 shares through Armorica Partners, LLC, where he is the managing director and sole shareholder.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine transaction, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and their potential impact on the stock's performance.
Key Dates
| Date | Description |
|---|---|
| 09/28/2024 | Date of transaction where shares were withheld for tax obligations. |
| 10/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.